Used as a potent agonist of the TrkB receptor, it mimics the effects of brain-derived neurotrophic factor (BDNF). This property makes it valuable in neuroscience research, particularly in studies related to neuroprotection, synaptic plasticity, and neuronal survival. It has shown potential in preclinical models for treating neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease. It is also investigated for its role in enhancing cognitive function, memory, and learning. Additionally, it exhibits antidepressant-like effects in animal models, suggesting possible applications in mood disorder research. Due to its ability to cross the blood-brain barrier, it is considered a promising candidate for developing therapies targeting central nervous system disorders.